Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial.

Bottini, A; Berruti, A; Brizzi, M P; Bersiga, A; Generali, D; Allevi, G; Aguggini, S; Bolsi, G; Bonardi, S; Tondelli, B; Vana, F; Tampellini, M; Alquati, P; Dogliotti, L

Bottini, A; Berruti, A; Brizzi, M P; Bersiga, A; Generali, D; Allevi, G; Aguggini, S; Bolsi, G; Bonardi, S; Tondelli, B; Vana, F; Tampellini, M; Alquati, P; Dogliotti, L.

Affiliation

Bottini A; Breast Unit and Anatomia Patologica Azienda Ospedaliera Istituti Ospitalieri, Cremona, Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Oncologia Medica, Azienda Ospedaliera San Luigi, Orbassano, Italy.

Endocr Relat Cancer ; 12(2): 383-92, 2005 Jun.

Article in En | MEDLINE | ID: mdl-15947110

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Epirubicin/therapeutic use; Tamoxifen/therapeutic use; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/metabolism; Epirubicin/administration & dosage; Epirubicin/adverse effects; Female; Humans; Ki-67 Antigen/analysis; Ki-67 Antigen/metabolism; Middle Aged; Neoplasm Staging; Tamoxifen/administration & dosage; Tamoxifen/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Epirubicin / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Endocr Relat Cancer Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2005 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links